Haemorrhagic disease of the newborn: Difference between revisions
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
__NOTOC__ | __NOTOC__ | ||
==Overview== | ==Overview== | ||
Line 32: | Line 32: | ||
{{Certain conditions originating in the perinatal period}} | {{Certain conditions originating in the perinatal period}} | ||
[[de:Morbus haemorrhagicus neonatorum]] | [[de:Morbus haemorrhagicus neonatorum]] |
Revision as of 15:46, 9 August 2012
Haemorrhagic disease of the newborn | |
Vitamin K1 | |
ICD-10 | P53 |
ICD-9 | 776.0 |
DiseasesDB | 29544 |
eMedicine | ped/966 |
MeSH | D006475 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Haemorrhagic disease of the newborn is a coagulation disturbance in newborns due to vitamin K deficiency. As a consequence of vitamin K deficiency there is an impaired production of coagulation factors II, VII, IX, X, C and S by the liver.
Causes
Newborns are relatively vitamin K deficient for a variety of reasons. They have low vitamin K stores at birth, vitamin K passes the placenta poorly, the levels of vitamin K in breast milk are low and the gut flora has not yet been developed (vitamin K is normally produced by bacteria in the intestines).
Presentation
The disease causes an increased risk of bleeding. The most common sites of bleeding are the umbilicus, mucous membranes, gastrointestinal tract, circumcision and venipunctures.
Treatment
Treatment consists of vitamin K supplementation. This is often given prophylactically newborns shortly after birth.
Template:Certain conditions originating in the perinatal period